Amar Singh

6PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 10, 2026
A Selective Pro-Oxidant Drives Redox Reprogramming to Induce Ferroptosis and Immune Remodeling in Glioblastoma.

|Jan 07, 2026
Allospecific splenic Tr1 cells drive effector T cell exhaustion through up-regulated Areg-EGFR signaling to promote transplant tolerance.

Amar Singh, Adam Herman, Devanjan Dey

|Jul 08, 2025
Glioblastoma at the crossroads: current understanding and future therapeutic horizons.

Shilpi Singh, Devanjan Dey, Debashis Barik

|Oct 14, 2023
Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment.

Shilpi Singh, Debashis Barik, Karl Lawrie

|Oct 27, 2021
Clinically available immunosuppression averts rejection but not systemic inflammation after porcine islet xenotransplant in cynomolgus macaques.

Melanie L Graham, Sabarinathan Ramachandran, Amar Singh

|Aug 04, 2019
Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes.

Amar Singh, Sabarinathan Ramachandran, Melanie L Graham

Pageof 1

Frequent Collaborators

3 joint publications

Sabarinathan Ramachandran

3 joint publications

Melanie L Graham

3 joint publications

Gatikrushna Singh

3 joint publications

Bernhard J Hering